Jose Carlos Machado

Full Professor @FMUPorto, PI @i3S_UPorto, #science, #scientist

[Jose Carlos Machado @joseclm]

Our latest study, published in Gut, reveals how mismatch repair-deficient colorectal tumors escape immune destruction while retaining immunogenic neoantigens that can be therapeutically targeted. @i3S_UPorto @FMUPorto @UPorto @NFdeMiranda @jlcosta_pt https://t.co/jRyLQ3ffcG

[#EHMSG @ehmsg]

Microbiota in Health and Disease - Submit your original research article free of charge! - https://t.co/l3Bd0sVg4g

[TOGAS EU project @Togas_euproject]

🤩 Yesterday, we held our Consortium Meeting in Porto, Portugal! Our partners discussed progress toward EU #GastricCancerScreeningGuidelines. We're excited to have our External Advisory Board join us in monitoring and addressing challenges. 🙌 #GastricCancer #EU

[#EHMSG @ehmsg]

Welcome to Prof. Gianluca Ianiro, President of EHMSG in 2025.
SAVE THE DATES for EHMSG 2025 in Rome, Italy on September 11 - 13, 2025!

[#EHMSG @ehmsg]

Congratulations to Prof Fatima Carneiro for receiving the Marshall & Warren Medal 2024!

[#EHMSG @ehmsg]

Welcome to the second day of the #EHMSG2024 conference! Session 1 starts at 8:30h. A full day of interesting sessions with invited speakers and varied presentations from submitted abstracts is ahead of you!

[Jose Carlos Machado @joseclm]

The XXXVIIth workshop of the EHMSG is on! Welcome to Porto! @ehmsg @i3S_UPorto @IPATIMUP @FMUPorto @portoponto @ASPICancro

[Microbiota in Health and Disease @MicrobHealthDis]

We are thrilled to announce the official Microbiota in Health and Disease Twitter account. 🦠🔬

Follow us for the latest #research, #updates, and #insights into the fascinating world of #microbiota and its impact on #health and #disease!

#Journal #OpenAccess #MicrobHealthDis

[Jose Carlos Machado @joseclm]

O Tratar o Cancro por Tu pela primeira vez em Faro. @IPATIMUP

[Jose Carlos Machado @joseclm]

Tratar o Cancro por Tu https://t.co/ePw6rzdVn3

[Jose Carlos Machado @joseclm]

Tratar o Cancro por Tu https://t.co/opMSy7m4ts

[Jose Carlos Machado @joseclm]

Sobrinho Simões: “O que vejo mais são casos em que o médico exagerou. Disse que era maligno e não era” https://t.co/a6GiWMLLay

[Jose Carlos Machado @joseclm]

Future perspective for the application of predictive biomarker testing in NSCLC. @ASPICancro
@i3S_UPorto @UPorto https://t.co/97n2s7Idc8

[Jose Carlos Machado @joseclm]

An overview of the development and current application of targeted therapies and predictive biomarker testing in European patients with advanced stage NSCLC. @ASPICancro @i3S_UPorto @UPorto
https://t.co/2E5FIwuhTv

[Jose Carlos Machado @joseclm]

Novo episódio disponível! https://t.co/y2SnANW5Yf

[Jose Carlos Machado @joseclm]

So proud of @barbaraadem, @Sonia_A_Melo and the whole team! https://t.co/9uFlKKbt1q @i3S_UPorto @FMUPorto @ASPICancro

[Jose Carlos Machado @joseclm]

Estamos de volta! @i3S_UPorto @ASPICancro @IPOPorto

[Jose Carlos Machado @joseclm]

https://t.co/jVVuaJJHcR
@i3S_UPorto
@IPATIMUP
@FMUPorto
@evitacancro
@FROC2009
@assoc_acreditar

[Jose Carlos Machado @joseclm]

O episódio 4 está disponível. https://t.co/HPkWJCtTkr @i3S_UPorto @IPATIMUP @FMUPorto @evitacancro @FROC2009 @assoc_acreditar

[Jose Carlos Machado @joseclm]

https://t.co/s7pYblnFQe @i3S_UPorto @IPATIMUP @FMUPorto @evitacancro @FROC2009 @assoc_acreditar